1. Fig. 3. Survival rates according to histologic diagnosis
Fig. 3. Survival rates according to histologic diagnosis. (A) OS and PFS in patients with brain tumors. (B) PFS according to the histologic diagnosis in patients with brain tumors. (C) OS and PFS in patients with neuroblastomas. (D) PFS according to the initial risk in patients with neuroblastomas. (E) OS and PFS in patients with bone and soft tissue sarcomas. (F) PFS according to the histologic diagnosis in patients with bone and soft tissue sarcomas. (G) OS and PFS in patients with Wilms tumor. (H) OS and PFS in patients with retinoblastoma. (I) OS and PFS in patients with other tumors. (J) PFS according to the histologic diagnosis in patients with other tumors. OS = overall survival, PFS = progression-free survival, MB = medulloblastoma, HGG = high-grade glioma, ATRT = atypical teratoid/rhabdoid tumor, AE = anaplastic ependymoma, PNET = primitive neuroectodermal tumor, IC-GCT = intracranial germ cell tumor, OSA = osteosarcoma, ESFT = Ewing sarcoma family of tumor, RMS = rhabdomyosarcoma, NRSTS = non-rhabdomyomatous soft tissue sarcoma, HB = hepatoblastoma, EC-GCT = extracranial germ cell tumor.
Fig. 3. Survival rates according to histologic diagnosis. (A) OS and PFS in patients with brain tumors. (B) PFS according to the histologic diagnosis in patients with brain tumors. (C) OS and PFS in patients with neuroblastomas. (D) PFS according to the initial risk in patients with neuroblastomas. (E) OS and PFS in patients with bone and soft tissue…
J Korean Med Sci Oct;33(41):e